134 related articles for article (PubMed ID: 65753)
1. Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man.
Shillitoe EJ; Tarro G; Lehner T
Oncology; 1976; 33(4):192-5. PubMed ID: 65753
[TBL] [Abstract][Full Text] [Related]
2. Immunopathology of oral leukoplakia.
Lehner T
Br J Cancer; 1970 Sep; 24(3):442-6. PubMed ID: 4319938
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
[TBL] [Abstract][Full Text] [Related]
4. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
[TBL] [Abstract][Full Text] [Related]
5. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
[TBL] [Abstract][Full Text] [Related]
6. Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.
Sprecher-Golberger S; Thiry L; de Halleux F; Bossens M; Gould I
Biomedicine; 1975 Nov; 23(9):399-401. PubMed ID: 182294
[No Abstract] [Full Text] [Related]
7. Cell-mediated immunity and antibodies to Herpesvirus hominis type 1 in oral leukoplakia and carcinoma.
Lehner T; Wilton JM; Shillitoe EJ; Ivanyi L
Br J Cancer; 1973 May; 27(5):351-61. PubMed ID: 4351511
[TBL] [Abstract][Full Text] [Related]
8. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration.
Russell AS; Kaiser J; Lao VS
J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120
[TBL] [Abstract][Full Text] [Related]
9. Cell mediated immunity to herpesvirus type 1 in carcinoma and pre-cancerous lesions.
Lehner T; Shillitoe EJ; Wilton JM; Ivanyi L
Br J Cancer Suppl; 1973 Aug; 1():128-34. PubMed ID: 4374226
[TBL] [Abstract][Full Text] [Related]
10. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
[TBL] [Abstract][Full Text] [Related]
11. Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.
Thong YH; Vincent MM; Hensen SA; Fuccillo DA; Rola-Pleszczynski M; Bellanti JA
Infect Immun; 1975 Jul; 12(1):76-80. PubMed ID: 166930
[TBL] [Abstract][Full Text] [Related]
12. Further studies on an immunoenzymatic assay for herpes simplex virus tumor-associated antigen.
Tarro G; Flaminio G; Maturo S; Esposito C; Cocchiara R
Clin Immunol Immunopathol; 1982 Oct; 25(1):126-32. PubMed ID: 6295672
[No Abstract] [Full Text] [Related]
13. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
Tarro G; Sabin AB
Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
[TBL] [Abstract][Full Text] [Related]
14. Human T cell response to Herpes simplex virus antigen in vitro.
Berle EJ; Thorsby E
Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):31-7. PubMed ID: 6246714
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex and herpes genitalis viruses in etiology of some human cancers.
Sabin AB; Tarro G
Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3225-9. PubMed ID: 4361685
[TBL] [Abstract][Full Text] [Related]
16. Unique immunobiological aspects of head and neck squamous carcinoma.
Chretien PB
Can J Otolaryngol; 1975; 4(2):225-35. PubMed ID: 166742
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
O'Reilly RJ; Chibbaro A; Anger E; Lopez C
J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
[TBL] [Abstract][Full Text] [Related]
18. Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera.
Eberle R; Mou SW
J Infect Dis; 1983 Sep; 148(3):436-44. PubMed ID: 6311910
[TBL] [Abstract][Full Text] [Related]
19. Letter: Possible prevention of bronchial carcinoma by recurrent Herpes simplex.
Ross CA; Tyrrell WF
Lancet; 1974 May; 1(7862):871. PubMed ID: 4132827
[No Abstract] [Full Text] [Related]
20. Studies of the nature of herpesvirus-induced tumour-associated antigens induced by herpes simplex virus type 1 and further analysis of their relationship with squamous-cell carcinomas of the head and neck region.
Hollinshead AC; Chretien PB; Tarpley JL
IARC Sci Publ (1971); 1975; (11 Pt 2):307-11. PubMed ID: 191376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
